Clinical trial
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
NCT05570994
Study timeline
Study start (actual)2024-01-01Date precision: day
Registry last updated2026-01-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancer Metastaticunresolved
Castrate Resistant Prostate Cancerunresolved
Interventions
177Lu HTK03170DRUG
68Ga-HTK03149DRUG
Sponsors & collaborators
British Columbia Cancer Agencylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05570994 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.